Vicarious Surgical (RBOT) Share-based Compensation (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Share-based Compensation came in at $7.1 million in Q3 2025, up 140.48% year-on-year from $2.9 million in Q3 2024, and up 12.22% on a QoQ basis from $6.3 million in Q2 2025.
Vicarious Surgical (RBOT) Share-based Compensation (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Share-based Compensation data on file, last reported at $7.1 million in Q3 2025.
- On a quarterly basis, Share-based Compensation rose 140.48% year-over-year to $7.1 million in Q3 2025; TTM through Sep 2025 was $7.1 million, a 41.96% decrease from a year earlier, with the FY2024 full-year figure at $11.9 million, down 10.27% from the prior year.
- Share-based Compensation for Q3 2025 stood at $7.1 million, up from $6.3 million in the prior quarter.
- Over the last five years, Share-based Compensation for RBOT reached as high as $11.9 million in Q4 2024 and fell as low as -$3.4 million in Q4 2022.
- Historically, Share-based Compensation has averaged $3.0 million across 5 years, with a median of $3.1 million in 2024.
- On a YoY basis, Share-based Compensation climbed as much as 894.28% in 2022 and fell as far as 212.2% in 2022.
- Year by year, Share-based Compensation stood at $3.0 million in 2021, then plunged by 212.2% to -$3.4 million in 2022, then surged by 189.91% to $3.1 million in 2023, then jumped by 287.06% to $11.9 million in 2024, then tumbled by 40.66% to $7.1 million in 2025.
- Per Business Quant data, the three most recent Share-based Compensation figures were $7.1 million in Q3 2025, $6.3 million in Q2 2025, and $546000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.06 Mn |
| Sep 30, 2025 | 7.06 Mn |
| Jun 30, 2025 | 6.29 Mn |
| Jun 30, 2025 | 6.29 Mn |
| Mar 31, 2025 | 546,000.00 |
| Mar 31, 2025 | 546,000.00 |
| Dec 31, 2024 | 11.90 Mn |
| Dec 31, 2024 | 11.90 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Dec 31, 2023 | 3.08 Mn |
| Dec 31, 2023 | 3.08 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Jun 30, 2023 | 3.32 Mn |
| Jun 30, 2023 | 3.32 Mn |